Literature DB >> 8092146

Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989.

B J Anía1, V J Suman, J L Sobell, M B Codd, M N Silverstein, L J Melton.   

Abstract

To investigate the suggestion that the incidence of polycythemia vera has increased in recent decades, we ascertained secular trends in the incidence of polycythemia vera in Olmsted County, Minnesota, over the 55-year period, 1935-1989. The inpatient and outpatient medical records of all potential cases of polycythemia vera in Olmsted County residents were reviewed and the diagnostic criteria of the Polycythemia Vera Study Group were applied. We found no indication of an increase in the age- and sex-adjusted incidence of polycythemia vera, which averaged 1.9 per 100,000 person-years (95% C.I., 1.4-2.5) over the study period. Incidence rates increased with age, and age-adjusted incidence rates were greater for men (2.8 per 100,000 person-years; 95% C.I., 1.8-3.9) than for women (1.3 per 100,000 person-years; 95% C.I., 0.7-1.9), with the highest incidence rate (23.5 per 100,000 person-years) among men aged 70-79 years. Survival was reduced in this inception cohort of 50 cases, compared to that expected for individuals of like age and sex (P < 0.0001); median survival following diagnosis was 7.2 years.

Entities:  

Mesh:

Year:  1994        PMID: 8092146     DOI: 10.1002/ajh.2830470205

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  13 in total

1.  Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study.

Authors:  François Girodon; Gilles Bonicelli; Céline Schaeffer; Morgane Mounier; Serge Carillo; Ingrid Lafon; Paule Marie Carli; Inès Janoray; Emmanuelle Ferrant; Marc Maynadié
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

2.  Central retinal artery occlusion as a presenting manifestation of polycythaemia vera.

Authors:  Karthik Rao; Shailaja Bhat Shenoy; Yogish Kamath; Smita Kapoor
Journal:  BMJ Case Rep       Date:  2016-10-20

3.  Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden.

Authors:  M Hultcrantz; A Ravn Landtblom; B Andréasson; J Samuelsson; P W Dickman; S Y Kristinsson; M Björkholm; T M-L Andersson
Journal:  J Intern Med       Date:  2020-01-11       Impact factor: 8.989

4.  Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study.

Authors:  Malin Hultcrantz; Sigurdur Yngvi Kristinsson; Therese M-L Andersson; Ola Landgren; Sandra Eloranta; Asa Rangert Derolf; Paul W Dickman; Magnus Björkholm
Journal:  J Clin Oncol       Date:  2012-07-16       Impact factor: 44.544

5.  New and old prognostic factors in polycythemia vera.

Authors:  Francesco Passamonti
Journal:  Curr Hematol Malig Rep       Date:  2009-01       Impact factor: 3.952

Review 6.  Clinical and scientific advances in the Philadelphia-chromosome negative chronic myeloproliferative disorders.

Authors:  Ruben A Mesa
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 7.  Austrian recommendations for the management of polycythemia vera.

Authors:  Sonja Burgstaller; Veronika Buxhofer-Ausch; Thamer Sliwa; Christine Beham-Schmid; Günther Gastl; Klaus Geissler; Thomas Melchardt; Maria Krauth; Peter Krippl; Andreas Petzer; Holger Rumpold; Albert Wölfler; Heinz Gisslinger
Journal:  Wien Klin Wochenschr       Date:  2018-07-19       Impact factor: 1.704

8.  Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.

Authors:  Holly L Geyer; Heidi Kosiorek; Amylou C Dueck; Robyn Scherber; Stefanie Slot; Sonja Zweegman; Peter Aw Te Boekhorst; Zhenya Senyak; Harry C Schouten; Federico Sackmann; Ana Kerguelen Fuentes; Dolores Hernández-Maraver; Heike L Pahl; Martin Griesshammer; Frank Stegelmann; Konstanze Döhner; Thomas Lehmann; Karin Bonatz; Andreas Reiter; Francoise Boyer; Gabriel Etienne; Jean-Christophe Ianotto; Dana Ranta; Lydia Roy; Jean-Yves Cahn; Claire N Harrison; Deepti Radia; Pablo Muxi; Norman Maldonado; Carlos Besses; Francisco Cervantes; Peter L Johansson; Tiziano Barbui; Giovanni Barosi; Alessandro M Vannucchi; Chiara Paoli; Francesco Passamonti; Bjorn Andreasson; Maria L Ferrari; Alessandro Rambaldi; Jan Samuelsson; Keith Cannon; Gunnar Birgegard; Zhijian Xiao; Zefeng Xu; Yue Zhang; Xiujuan Sun; Junqing Xu; Jean-Jacques Kiladjian; Peihong Zhang; Robert Peter Gale; Ruben A Mesa
Journal:  Haematologica       Date:  2016-08-18       Impact factor: 9.941

9.  Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?

Authors:  Maurizio Zangari; Louis Fink; Giulia Tolomelli; Jasmine C H Lee; Brady L Stein; Kimberly Hickman; Sabina Swierczek; Todd W Kelley; Tamara Berno; Alison R Moliterno; Jerry L Spivak; Victor R Gordeuk; Josef T Prchal
Journal:  Blood Coagul Fibrinolysis       Date:  2013-04       Impact factor: 1.276

10.  When the Brakes are Lost: LNK Dysfunction in Mice, Men, and Myeloproliferative Neoplasms.

Authors:  Stephen T Oh
Journal:  Ther Adv Hematol       Date:  2011-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.